New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Akoya Biosciences, Inc.
AKYA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

142M

Medical - Instruments & Supplies

Next Earning date - 13 Nov 2024

142M

Medical - Instruments & Supplies

Next Earning date - 13 Nov 2024

2.87USD
Shape0.07 ( 2.50%)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-73%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

55%

Quote Panel

Shape
Updated October 25, 2024
1W -4.65 % 1M 5.90 % 3M 16.67 % 1Y -12.23 %

Key Metrics

Shape
  • Market Cap

    142.06M


  • Shares Outstanding

    49.50M


  • Share in Float

    22.12M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    2.87


  • Average Volume

    154751


  • Beta

    1.364


  • Range

    1.88-6.31


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.akoyabio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.53x

P/S Ratio

6.41x

P/B Ratio

3.6

Debt/Equity

-64.7%

Net Margin

$-1.2

EPS

How AKYA compares to sector?

P/E Ratio

Relative Strength

Shape

AKYA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$116M

Shape401%

2025-Revenue

$0.55

Shape-102%

2025-EPS

$54M

Shape-492%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Overweight

2024-08-06

Now: Equal-Weight

BTIG

downgrade

Previous: Buy

2024-08-06

Now: Neutral

Craig-Hallum

initialise

Previous: Not converted

2024-06-21

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.47
vs -0.31

Q4.22

arrow
arrow

N/A

-0.50
vs -0.47

Q1.23

arrow
arrow

N/A

-0.49
vs -0.44

Q2.23

arrow
arrow

N/A

-0.51
vs -0.47

Q3.23

arrow
arrow

N/A

-0.26
vs -0.47

Q4.23

arrow
arrow

N/A

-0.22
vs -0.50

Q1.24

arrow
arrow

N/A

-0.35
vs -0.49

Q2.24

arrow
arrow

N/A

-0.27
vs -0.51

Q3.24

arrow
arrow

N/A

-0.20
vs -0.26

Q4.24

arrow
arrow

N/A

-0.10
vs -0.22

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+40%

18.9M  vs 13.5M

Q4.22

arrow
arrow

+31%

21.2M  vs 16.2M

Q1.23

arrow
arrow

+27%

21.4M  vs 16.9M

Q2.23

arrow
arrow

+31%

23.5M  vs 17.9M

Q3.23

arrow
arrow

+34%

25.2M  vs 18.9M

Q4.23

arrow
arrow

+25%

26.5M  vs 21.2M

Q1.24

arrow
arrow

-14%

18.4M  vs 21.4M

Q2.24

arrow
arrow

-2%

23.2M  vs 23.5M

Q3.24

arrow
arrow

+1%

25.4M  vs 25.2M

Q4.24

arrow
arrow

+16%

30.8M  vs 26.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-24%

-0.24
vs -0.19

Q4.22

arrow
arrow

-32%

-0.32
vs -0.24

Q1.23

arrow
arrow

-45%

-0.45
vs -0.32

Q2.23

arrow
arrow

-29%

-0.29
vs -0.45

Q3.23

arrow
arrow

-21%

-0.21
vs -0.29

Q4.23

arrow
arrow

-20%

-0.20
vs -0.21

Q1.24

arrow
arrow

-72%

-0.72
vs -0.20

Q2.24

arrow
arrow

-59%

-0.59
vs -0.72

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

61

61
vs 54

13%

Q4.22

arrow
arrow

73

73
vs 61

20%

Q1.23

arrow
arrow

65

65
vs 73

-11%

Q2.23

arrow
arrow

77

77
vs 65

18%

Q3.23

arrow
arrow

64

64
vs 77

-17%

Q4.23

arrow
arrow

66

66
vs 64

3%

Q1.24

arrow
arrow

68

68
vs 66

3%

Q2.24

arrow
arrow

60

60
vs 68

-12%

Earnings Growth

Latest News